- Home
- SNTI vs MTEK Comparison
SNTI vs MTEK Comparison
Compare SNTI & MTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- MTEK
- Stock Information
- Founded
- SNTI 2016
- MTEK 2008
- Country
- SNTI United States
- MTEK Israel
- Employees
- SNTI N/A
- MTEK N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- MTEK
- Sector
- SNTI Health Care
- MTEK
- Exchange
- SNTI Nasdaq
- MTEK Nasdaq
- Market Cap
- SNTI 39.6M
- MTEK 24.0M
- IPO Year
- SNTI N/A
- MTEK 2022
- Fundamental
- Price
- SNTI $1.35
- MTEK $3.07
- Analyst Decision
- SNTI Strong Buy
- MTEK
- Analyst Count
- SNTI 2
- MTEK 0
- Target Price
- SNTI $8.50
- MTEK N/A
- AVG Volume (30 Days)
- SNTI 128.8K
- MTEK 92.9K
- Earning Date
- SNTI 08-07-2025
- MTEK 09-05-2025
- Dividend Yield
- SNTI N/A
- MTEK N/A
- EPS Growth
- SNTI N/A
- MTEK N/A
- EPS
- SNTI N/A
- MTEK N/A
- Revenue
- SNTI N/A
- MTEK $6,078,953.00
- Revenue This Year
- SNTI N/A
- MTEK N/A
- Revenue Next Year
- SNTI $150.00
- MTEK N/A
- P/E Ratio
- SNTI N/A
- MTEK N/A
- Revenue Growth
- SNTI N/A
- MTEK 50.80
- 52 Week Low
- SNTI $1.26
- MTEK $1.61
- 52 Week High
- SNTI $16.94
- MTEK $6.47
- Technical
- Relative Strength Index (RSI)
- SNTI 33.68
- MTEK 55.22
- Support Level
- SNTI $1.38
- MTEK $2.97
- Resistance Level
- SNTI $1.39
- MTEK $3.32
- Average True Range (ATR)
- SNTI 0.08
- MTEK 0.27
- MACD
- SNTI 0.00
- MTEK 0.05
- Stochastic Oscillator
- SNTI 22.50
- MTEK 66.31
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About MTEK Maris-Tech Ltd.
Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.